A research conducted by a team of researchers from La Jolla Institute for Allergy & Immunology has unveiled the gene responsible for stimulating the body’s immune system every time fatal viruses and pathogens attack the body. The stimulation of the immune system results in the production of disease-fighting antibodies in the body. The study finding is significant as it would help the researchers understand the molecular steps that activate the body’s immune system when the body is in danger.

Testing by Brunswick Laboratories has determined that each Vindure 900 tablet from Vinomis Laboratories has an ORAC rating of 19,638, which is more than six times the USDA recommended daily consumption level of antioxidants. The antioxidant power of Vindure comes from a hefty dose of its three primary ingredients: over 400mg of 98% pure trans-Resveratrol, 100mg of pure Quercetin, and 400mg of red wine grape extract containing over 90% polyphenols.

Agilent Technologies Inc has introduced the SureSelect DNA Capture Array, removing a major bottleneck in small-scale DNA studies by enabling scientists sequence only genomic areas of interest with next-generation sequencing (NGS) instruments. Designed for smaller studies, the SureSelect DNA Capture Arrays complement Agilent’s in-solution SureSelect Target Enrichment System, which is designed for medium to large-scale NGS studies of tens through thousands of samples, including automated high-throughput workflows.

A new study, led by Usha Chakravarthy of Queen’s University in Belfast, has indicated that antioxidants found in fruit and vegetables may decelerate sight loss in many elderly people. The study showed that high intake of antioxidants preserved the muscular pigments, slowing down the progression from early age-related muscular regeneration (AMD) to late AMD.

Researchers from Canada and Australia have found that a new antibody that specifically targets cancer stem cells might be helpful in treating an aggressive type of leukemia. The therapeutic molecule created by these researchers attacks a protein, CD123, on the surface of cancer stem cells, which sustain acute myeloid leukemia (AML). This type of leukemia is difficult to treat because it does not respond well to standard chemotherapy.